SCHEMBL4585506

SCHEMBL4585506

COCOc1cc(/C=C/c2cc3c(c(OC)c2)OC2(C)CCC(O)C(C)(C)C2C3)cc(OCOC)c1C/C=C(\C)CC/C=C(\C)CO

nearest known ligand 0.65

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
OSBP P22059 16/20 0.65
OSBP2 Q969R2 1/20 0.48
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12042835 1.00 OSBP (0.65) OSBPOSBP2PPARGPPARAMAPT
SCHEMBL2071814 1.00 OSBP (0.65) OSBPOSBP2PPARGPPARAMAPT
SCHEMBL12042778 0.95 OSBP (0.70) OSBPOSBP2PPARGPPARAMAPT
SCHEMBL12845471 0.94 OSBP (0.69) OSBPOSBP2PPARGPPARAMAPT
SCHEMBL2073637 0.91 OSBP (0.80) OSBPOSBP2PPARGPPARA
SCHEMBL2073634 0.91 OSBP (0.80) OSBPOSBP2PPARGPPARA
SCHEMBL12783001 0.89 OSBP (0.76) OSBPOSBP2PPARGPPARA
SCHEMBL2071812 0.88 OSBP (0.64) OSBPOSBP2MAPT
3-Deoxyschweinfurthin B SCHEMBL10043035 0.85 OSBP (0.86) OSBPOSBP2PPARGPPARA
SCHEMBL2073578 0.84 OSBP (0.72) OSBPOSBP2PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732915-B1 SCHWEINFURTHIN ANALOGUES UNIV IOWA RES FOUND (US) 2016-01-06 EP disclosed
US-20110319481-A1 SCHWEINFURTHIN ANALOGUES Government of the United States of America, National Institute of Health (US) 2011-12-29 US disclosed
US-7358377-B2 such as: 3-Deoxyschweinfurthin B; tested and were found to have anti-cancer by NCI 60-cell line anticancer assay; e.g. breast cancer or a cancer of the CNS or renal system UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2008-04-15 US disclosed
US-20080015232-A1 SCHWEINFURTHIN ANALOGUES US GOVERNMENT - SECRETARY FOR THE ARMY 2008-01-17 US disclosed
EP-1732915-A2 SCHWEINFURTHIN ANALOGUES UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2006-12-20 EP disclosed
WO-2005092878-A2 SCHWEINFURTHIN ANALOGUES UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015232-A1 SCHWEINFURTHIN ANALOGUES ERH, HRAS, HNRNPH1 OSBP 2083/4885OSBP2 2163/4885PPARG 1653/4885
US-20110319481-A1 SCHWEINFURTHIN ANALOGUES ERH, HRAS, HNRNPH1 OSBP 2083/4885OSBP2 2163/4885PPARG 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.